Ghady Haidar

@cleverwebber

Pitt Transplant Infectious Diseases physician-researcher with a flair for the dramatique. I want ev’rybody to be free.

Pittsburgh, PA
Vrijeme pridruživanja: siječanj 2010.

Tweetovi

Blokirali ste korisnika/cu @cleverwebber

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cleverwebber

  1. Prikvačeni tweet
    22. ruj 2018.

    When it’s 3:00 am and you haven’t stepped inside an OR since 2008 but are delighted that HIV-to-HIV have made it to Pittsburgh @pos_rhetoric

    Poništi
  2. proslijedio/la je Tweet
    4. velj

    I love women supporting women! Happy National Women Physician Day! I know I'll forget some people!

    Poništi
  3. proslijedio/la je Tweet
    4. velj

    Lady friends! It’s apparently . Or as I call it, Monday. We go girls!! 😘

    Poništi
  4. 3. velj

    Question for : in AML/BMT patients w/ known or suspected pulmonary mucormycosis, how successful have you been at achieving "source control" via chest tubes/VATS (for effusions) or pneumonectomies? I find this extremely unchallenging, unlike sinusitis/cutaneous disease.

    Poništi
  5. 2. velj
    Poništi
  6. 2. velj

    2 things that bother me about the “proofing” process: 1. Why do they demand revisions in 48 hours? Too dramatic. Not cool. 2. Why is it my job to review references and tell them the page number of the citation or the publisher of the book? I don’t actually know any of this.

    Poništi
  7. 1. velj

    Populist nonsense. The UK will live to regret this most grievous day. What a terrible idea this whole thing was. It breaks my heart.

    Poništi
  8. 29. sij

    Can we please focus on the existing and vaccine-preventable threat and of ? Too much hysteria is being directed toward

    Poništi
  9. 29. sij
    Poništi
  10. 29. sij

    I’d respond with this absurdist song from : “The Irma Luhrman-Merman murder Turned the bird's word lurid The whir & the purr of a twirler girl She would the world were demurer The insurer's allure For valor were pure Kari Wuhrer One fervid whirl over her turgid error.”

    Poništi
  11. 28. sij

    Back on heart/lung transplant ID service. Initial musings: 1) it’s good to have a vast network of national and international colleagues, as well as the infrastructure of and OPOs like . 2) Much to be grateful for.

    Poništi
  12. 25. stu 2019.
    Poništi
  13. 25. stu 2019.

    Cancer centers of the world unite! Study design should be relatively simple. Perhaps a straightforward FLUC vs POSA comparison a la the landmark 2007 trials by and Ullmann?

    Poništi
  14. 23. stu 2019.

    Glad you like it! At least in 2019, we aren’t embarking on this blind: we know how molds infect heme-onc patients because of the DECADES of clinical & research experience we have to draw from. How do we apply these concepts to CART? Molds are still devastating

    Poništi
  15. 21. stu 2019.

    Anyone have any insights about why this ISA vs FLUC trial is "active, not recruiting"? Sounds ominous. The azole + HMA/midostaurin thing is quite tiresome.

    Poništi
  16. 10. stu 2019.
    Poništi
  17. 7. stu 2019.

    An inspirational talk by Dr. Nina Singh! Future research on CMV elimination after SOT must focus on donor factors that influence CMV transmission and everyone else

    Poništi
  18. 3. stu 2019.

    Inertial dogma! Self-fulfilling prophecy etc.

    Poništi
  19. proslijedio/la je Tweet
    3. stu 2019.

    Okay ID Twitter, you asked, so I tried. How does below look as pilot re-design of Shorter Is Better table? Added in the 1 negative RCT of fluclox for cellulitis in footnote, too. I think I can't fit total N on the slide, but maybe I could on website. Thoughts? Re-design further?

    Poništi
  20. 30. lis 2019.

    I learned today that an outpatient azole treatment course for one one my patients with aspergillosis would cost over $15,000. For a few months of POSA/ISA. That's like a car. Or a house in Detroit, or a luxury flight to Singapore according to this site:

    Poništi
  21. 24. lis 2019.

    "We don’t have to put up with this. Health care in the United States is shockingly opaque; it’s time to take insurance companies out of our decision-making process." A sentiment expressed by every single clinician I know. And yet nothing is done. How can we actually change this?

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·